BioSpace News Archive

Bio NC

Diet Drugs Battle: Will Arena Pharmaceuticals, Inc./Eisai Inc. Belviq’s Aggressive Marketing Quash Weakened VIVUS, Inc.'s Qsymia

June 24, 2013
·
2 min read
Drug Development

Janssen Research & Development Release: Studies Reinforce INVOKANA™ (canagliflozin) (300mg) Provides Greater Improvements in Blood Glucose Than Sitagliptin (100 mg) or Glimepiride (6 or 8 mg) in Adults With Type 2 Diabetes

June 24, 2013
·
16 min read
Policy

Good Start Genetics, Inc. Receives Approval to Conduct Genetic Screening in New York

June 24, 2013
·
1 min read
Quintiles, Inc. Named Britain’s Healthiest Large Company

June 24, 2013
·
1 min read
Drug Development

Nimbus Discovery Presents Compelling Preclinical Proof of Concept Data on Novel ACC Allosteric Inhibitor ND-630

June 24, 2013
·
1 min read
Deals

Prollenium Medical Technologies Reacquires Ovita® HV Brand for Global Distribution

June 24, 2013
·
2 min read
Drug Development

Lexicon Pharmaceuticals, Inc. Presents Preclinical Data on LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract

June 24, 2013
·
4 min read
Genetown

PAREXEL International Launches New Functional Services Unit

June 24, 2013
·
5 min read
Business

SpectraScience, Inc. Announces Minimum Purchase Agreement With PENTAX Medical Company

June 24, 2013
·
1 min read
Pharm Country

Animas Corporation Makes Progress in Development of a First-Generation Closed-Loop Insulin Delivery System With Study Participants Maintaining Safe Glucose Levels for Over 90 Percent of the Overnight Period

June 24, 2013
·
4 min read